BiotechTube
Home/Zai Lab/Rafael G. Amado
RG

Rafael G. Amado

President, Head of Global Research and Development

Zai Lab

Therapeutic Areas

OncologyImmunologyNeuroscienceInfectious Disease

Zai Lab Pipeline

DrugIndicationPhase
zocilurtatug pelitecan (ZL-1310)Small Cell Lung Cancer (2L extensive-stage)Phase 3
ZL-1503Atopic DermatitisPhase (Early Clinical)
ZL-6201Solid TumorsPhase (Early Clinical)
AUGTYRO™ (repotrectinib)NTRK-Positive Solid TumorsApproved
COBENFY® (xanomeline/trospium)SchizophreniaApproved
NUZYRA® (omadacycline)CABP & ABSSSICommercial
QINLOCK® (ripretinib)Advanced GISTCommercial
AdagrasibKRAS G12C-mutated NSCLCCommercial/Approved

Leadership Team at Zai Lab

SD
Samantha Du
Founder, Chairperson and Chief Executive Officer
PC
Prista Charuworn
Vice President, Global Clinical Development, Neuroscience & Immunology (NSI)
YC
Yajing Chen
Chief Financial Officer
CC
Christine Chiou
Senior Vice President, Head of Investor Relations
FT
F. Ty Edmondson
Chief Legal Officer and Corporate Secretary
SH
Shan He
Senior Vice President, Chief Business Officer
JS
Josh Smiley
President and Chief Operating Officer
JY
James Yan
Chief Operating Officer, Global R&D
AZ
Andrew Zhu
Chief Commercial Officer, Greater China
JD
John D. Diekman
Board of Directors
View full Zai Lab profile